Genomic characteristics, survival, and prognostic analysis of advanced non-small cell lung cancer with KRAS mutations and brain metastases
Background The brain is a common site of metastasis in lung cancer. However, data on the incidence of brain metastases (BM) and survival outcomes among patients with non-small cell lung cancer (NSCLC) harboring KRAS mutations, particularly those receiving tyrosine kinase inhibitors (TKIs), remain limited. This single-c...